OLEMA PHARMACEUTICALS INC (OLMA) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:OLMA • US68062P1066

25.36 USD
+0.35 (+1.4%)
At close: Feb 6, 2026
25.86 USD
+0.5 (+1.97%)
After Hours: 2/6/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall OLMA gets a fundamental rating of 2 out of 10. We evaluated OLMA against 524 industry peers in the Biotechnology industry. While OLMA seems to be doing ok healthwise, there are quite some concerns on its profitability. OLMA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • OLMA had negative earnings in the past year.
  • In the past year OLMA has reported a negative cash flow from operations.
  • OLMA had negative earnings in each of the past 5 years.
  • In the past 5 years OLMA always reported negative operating cash flow.
OLMA Yearly Net Income VS EBIT VS OCF VS FCFOLMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M

1.2 Ratios

  • OLMA's Return On Assets of -42.55% is in line compared to the rest of the industry. OLMA outperforms 57.44% of its industry peers.
  • With a decent Return On Equity value of -48.77%, OLMA is doing good in the industry, outperforming 67.56% of the companies in the same industry.
Industry RankSector Rank
ROA -42.55%
ROE -48.77%
ROIC N/A
ROA(3y)-37.4%
ROA(5y)-28.65%
ROE(3y)-40.93%
ROE(5y)-30.97%
ROIC(3y)N/A
ROIC(5y)N/A
OLMA Yearly ROA, ROE, ROICOLMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

  • OLMA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OLMA Yearly Profit, Operating, Gross MarginsOLMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, OLMA has more shares outstanding
  • Compared to 5 years ago, OLMA has more shares outstanding
  • OLMA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
OLMA Yearly Shares OutstandingOLMA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OLMA Yearly Total Debt VS Total AssetsOLMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • OLMA has an Altman-Z score of 23.51. This indicates that OLMA is financially healthy and has little risk of bankruptcy at the moment.
  • OLMA has a better Altman-Z score (23.51) than 90.84% of its industry peers.
  • OLMA has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.01, OLMA is in line with its industry, outperforming 45.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 23.51
ROIC/WACCN/A
WACCN/A
OLMA Yearly LT Debt VS Equity VS FCFOLMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • OLMA has a Current Ratio of 8.03. This indicates that OLMA is financially healthy and has no problem in meeting its short term obligations.
  • OLMA's Current ratio of 8.03 is fine compared to the rest of the industry. OLMA outperforms 74.43% of its industry peers.
  • A Quick Ratio of 8.03 indicates that OLMA has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 8.03, OLMA is doing good in the industry, outperforming 74.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.03
Quick Ratio 8.03
OLMA Yearly Current Assets VS Current LiabilitesOLMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • OLMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.61%, which is quite good.
EPS 1Y (TTM)14.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 0.79% on average over the next years.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y12.97%
EPS Next 2Y-4.4%
EPS Next 3Y-7.47%
EPS Next 5Y0.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OLMA Yearly Revenue VS EstimatesOLMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
OLMA Yearly EPS VS EstimatesOLMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • OLMA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OLMA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OLMA Price Earnings VS Forward Price EarningsOLMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OLMA Per share dataOLMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

  • A cheap valuation may be justified as OLMA's earnings are expected to decrease with -7.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.4%
EPS Next 3Y-7.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • OLMA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OLEMA PHARMACEUTICALS INC

NASDAQ:OLMA (2/6/2026, 8:00:02 PM)

After market: 25.86 +0.5 (+1.97%)

25.36

+0.35 (+1.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-10
Earnings (Next)03-02
Inst Owners89.36%
Inst Owner Change-0.99%
Ins Owners2.98%
Ins Owner Change-11.69%
Market Cap1.99B
Revenue(TTM)N/A
Net Income(TTM)-149.96M
Analysts86.67
Price Target46.51 (83.4%)
Short Float %11.97%
Short Ratio3.34
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.15%
Min EPS beat(2)-32.98%
Max EPS beat(2)0.67%
EPS beat(4)3
Avg EPS beat(4)5.09%
Min EPS beat(4)-32.98%
Max EPS beat(4)30.8%
EPS beat(8)5
Avg EPS beat(8)2.82%
EPS beat(12)8
Avg EPS beat(12)5.27%
EPS beat(16)10
Avg EPS beat(16)3.66%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.37%
PT rev (3m)89.76%
EPS NQ rev (1m)0.66%
EPS NQ rev (3m)-4.88%
EPS NY rev (1m)0.15%
EPS NY rev (3m)-3.04%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.49
P/tB 6.49
EV/EBITDA N/A
EPS(TTM)-1.87
EYN/A
EPS(NY)-2.41
Fwd EYN/A
FCF(TTM)-1.71
FCFYN/A
OCF(TTM)-1.71
OCFYN/A
SpS0
BVpS3.91
TBVpS3.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -42.55%
ROE -48.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-37.4%
ROA(5y)-28.65%
ROE(3y)-40.93%
ROE(5y)-30.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.03
Quick Ratio 8.03
Altman-Z 23.51
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)46.82%
Cap/Depr(5y)345.59%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.33%
EPS Next Y12.97%
EPS Next 2Y-4.4%
EPS Next 3Y-7.47%
EPS Next 5Y0.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-16.93%
EBIT Next 3Y-16.67%
EBIT Next 5YN/A
FCF growth 1Y-58.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-58.49%
OCF growth 3YN/A
OCF growth 5YN/A

OLEMA PHARMACEUTICALS INC / OLMA FAQ

What is the ChartMill fundamental rating of OLEMA PHARMACEUTICALS INC (OLMA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to OLMA.


What is the valuation status of OLEMA PHARMACEUTICALS INC (OLMA) stock?

ChartMill assigns a valuation rating of 0 / 10 to OLEMA PHARMACEUTICALS INC (OLMA). This can be considered as Overvalued.


How profitable is OLEMA PHARMACEUTICALS INC (OLMA) stock?

OLEMA PHARMACEUTICALS INC (OLMA) has a profitability rating of 1 / 10.


What is the earnings growth outlook for OLEMA PHARMACEUTICALS INC?

The Earnings per Share (EPS) of OLEMA PHARMACEUTICALS INC (OLMA) is expected to grow by 12.97% in the next year.